REGENXBIO Provides Year-End 2016 Corporate Update
Jan 06, 2017 13:50 pm UTC| Business
Filed IND for RGX-314 Phase I clinical trial for wet AMDAnnounced initiation of protocol changes for RGX-501 Phase I/II clinical trial for HoFH; patient enrollment is now projected to begin first half 2017Anticipate...
Jan 06, 2017 13:48 pm UTC| Business
Dublin, Jan. 06, 2017 -- Research and Markets has announced the addition of the "Noise Vibration Harshness (NVH) Testing Market by Type, Application - Global Forecast to 2022" report to their offering. ...
Radius Health to Present at the 35th Annual J.P. Morgan Healthcare Conference
Jan 06, 2017 13:40 pm UTC| Business
WALTHAM, Mass., Jan. 06, 2017 -- Radius Health, Inc. (Nasdaq:RDUS), a science-driven biopharmaceutical company focused on developing innovative therapeutics in the areas of osteoporosis, oncology and endocrine diseases,...
Jan 06, 2017 13:39 pm UTC| Business
Dublin, Jan. 06, 2017 -- Research and Markets has announced the addition of the "Prefilled Syringes Market by Material (Glass, Plastic), Type (Conventional, Safety), Design (Dual Single-Chamber,...
Jan 06, 2017 13:30 pm UTC| Business
BETHESDA, Md., Jan. 06, 2017 -- TerraForm Power, Inc. (Nasdaq:TERP) (“TerraForm Power” or the “Company”), an owner and operator of clean energy power plants, today announced that its subsidiary, TerraForm Power...
Jan 06, 2017 13:30 pm UTC| Business
WARREN N.J., Jan. 06, 2017 -- MonoSol Rx, a specialty pharmaceutical company leveraging its PharmFilm® drug delivery technology to improve patient outcomes and to address unmet needs, today announced the completion of a...
Tyme Technologies Announces Hiring of Shabnam Stanicky as Clinical Operations Officer
Jan 06, 2017 13:30 pm UTC| Business
NEW YORK, Jan. 06, 2017 -- Tyme Technologies, Inc. (OTCQB:TYMI), a clinical-stage biotechnology company developing cancer therapeutics that are designed to be effective across multiple tumor types, announced the...